Literature DB >> 24222315

Treatment of dementia with lewy bodies.

Brendon P Boot1, Eric M McDade, Scott M McGinnis, Bradley F Boeve.   

Abstract

OPINION STATEMENT: Dementia with Lewy bodies (DLB) is a multisystem disorder with diverse disease expression. A treatment regime restricted to the cognitive aspects of the disease does no favor to patients. Instead, patients should be educated to recognize the symptoms of this multisystem involvement. There are no treatments that slow the progression of disease, but symptomatic treatments can be effective. When thinking about treatment, we find it useful to divide the symptoms and signs into five categories: (a) cognitive features, (b) neuropsychiatric features, (c) motor dysfunction, (d) autonomic dysfunction, and (e) sleep dysfunction. Clinicians, funding bodies and industry are increasingly recognizing the importance of this common and debilitating disease.

Entities:  

Year:  2013        PMID: 24222315      PMCID: PMC3913181          DOI: 10.1007/s11940-013-0261-6

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  111 in total

1.  Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study.

Authors:  Camila Andrade Mendes Medeiros; Pedro Felipe Carvalhedo de Bruin; Lívia Ariane Lopes; Maria Cecília Magalhães; Maria de Lourdes Seabra; Veralice Meireles Sales de Bruin
Journal:  J Neurol       Date:  2007-04-03       Impact factor: 4.849

2.  Massage in the management of agitation in nursing home residents with cognitive impairment.

Authors:  Diane M Holliday-Welsh; Charles E Gessert; Colleen M Renier
Journal:  Geriatr Nurs       Date:  2009 Mar-Apr       Impact factor: 2.361

3.  Neurodegenerative Disease and REM Behavior Disorder.

Authors:  Raman Malhotra; Alon Y Avidan
Journal:  Curr Treat Options Neurol       Date:  2012-10       Impact factor: 3.598

4.  Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease.

Authors:  C Ballard; J Grace; I McKeith; C Holmes
Journal:  Lancet       Date:  1998-04-04       Impact factor: 79.321

5.  Meta-analysis of nonpharmacological interventions for neuropsychiatric symptoms of dementia.

Authors:  Henry Brodaty; Caroline Arasaratnam
Journal:  Am J Psychiatry       Date:  2012-09       Impact factor: 18.112

6.  Clinical and neuropathological correlates of Lewy body disease.

Authors:  Nozomi Hishikawa; Yoshio Hashizume; Mari Yoshida; Gen Sobue
Journal:  Acta Neuropathol       Date:  2003-01-14       Impact factor: 17.088

7.  Lewy bodies and response to tacrine in Alzheimer's disease.

Authors:  R Levy; S Eagger; M Griffiths; E Perry; M Honavar; A Dean; P Lantos
Journal:  Lancet       Date:  1994-01-15       Impact factor: 79.321

8.  Macrogol for the treatment of constipation in Parkinson's disease. A randomized placebo-controlled study.

Authors:  Roberta Zangaglia; Emilia Martignoni; Margaret Glorioso; Maria Ossola; Giulio Riboldazzi; Daniela Calandrella; Gabriele Brunetti; Claudio Pacchetti
Journal:  Mov Disord       Date:  2007-07-15       Impact factor: 10.338

Review 9.  Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia: a literature review.

Authors:  Sergiy Konovalov; Sunanda Muralee; Rajesh R Tampi
Journal:  Int Psychogeriatr       Date:  2007-11-30       Impact factor: 3.878

10.  The neuropathology of older persons with and without dementia from community versus clinic cohorts.

Authors:  Julie A Schneider; Neelum T Aggarwal; Lisa Barnes; Patricia Boyle; David A Bennett
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

View more
  8 in total

Review 1.  Lewy Body Disease: Clinical and Pathological "Overlap Syndrome" Between Synucleinopathies (Parkinson Disease) and Tauopathies (Alzheimer Disease).

Authors:  Clovis Foguem; Patrick Manckoundia
Journal:  Curr Neurol Neurosci Rep       Date:  2018-04-08       Impact factor: 5.081

Review 2.  Lewy body dementias.

Authors:  Zuzana Walker; Katherine L Possin; Bradley F Boeve; Dag Aarsland
Journal:  Lancet       Date:  2015-10-24       Impact factor: 79.321

3.  Comprehensive treatment of dementia with Lewy bodies.

Authors:  Brendon P Boot
Journal:  Alzheimers Res Ther       Date:  2015-05-29       Impact factor: 6.982

Review 4.  Burden of Disease and Current Management of Dementia with Lewy Bodies: A Literature Review.

Authors:  Amir Abbas Tahami Monfared; Genevieve Meier; Richard Perry; Darren Joe
Journal:  Neurol Ther       Date:  2019-09-12

Review 5.  Coping with Dementia in the Middle of the COVID-19 Pandemic.

Authors:  Nayoung Ryoo; Jung Min Pyun; Min Jae Baek; Jeewon Suh; Min Ju Kang; Min Jeong Wang; Young Chul Youn; Dong Won Yang; Seong Yoon Kim; Young Ho Park; SangYun Kim
Journal:  J Korean Med Sci       Date:  2020-11-02       Impact factor: 2.153

Review 6.  Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions.

Authors:  Claudia Carrarini; Mirella Russo; Fedele Dono; Filomena Barbone; Marianna G Rispoli; Laura Ferri; Martina Di Pietro; Anna Digiovanni; Paola Ajdinaj; Rino Speranza; Alberto Granzotto; Valerio Frazzini; Astrid Thomas; Andrea Pilotto; Alessandro Padovani; Marco Onofrj; Stefano L Sensi; Laura Bonanni
Journal:  Front Neurol       Date:  2021-04-16       Impact factor: 4.003

Review 7.  Lewy body dementia: the impact on patients and caregivers.

Authors:  Yael R Zweig; James E Galvin
Journal:  Alzheimers Res Ther       Date:  2014-04-25       Impact factor: 6.982

8.  Depressive symptoms are associated with daytime sleepiness and subjective sleep quality in dementia with Lewy bodies.

Authors:  Greg J Elder; Sean J Colloby; Debra J Lett; John T O'Brien; Kirstie N Anderson; David J Burn; Ian G McKeith; John-Paul Taylor
Journal:  Int J Geriatr Psychiatry       Date:  2015-11-11       Impact factor: 3.485

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.